Pfizer (PFE) Construction in Progress (2009 - 2013)

Pfizer (PFE) has reported Construction in Progress for 5 consecutive years, with $1.1 billion the latest figure, recorded in Q4 2013.

• On a quarterly basis, Construction in Progress rose 15.15% year-over-year to $1.1 billion in Q4 2013; TTM through Dec 2013 was $1.1 billion, a 15.15% increase from a year earlier, with the FY2013 full-year figure at $1.1 billion, up 15.15% from the prior year.
• Construction in Progress was $1.1 billion for Q4 2013 at Pfizer, up from $957.0 million in the prior quarter.
• Over five years, Construction in Progress peaked at $2.0 billion in Q4 2009 and troughed at $957.0 million in Q4 2012.
• A 5-year average of $1.3 billion and a median of $1.1 billion in 2013 frame the typical range for Construction in Progress.
• Across the five-year window, Construction in Progress slumped 49.19% in 2010 and increased 29.53% in 2011, its largest moves.
• Over 5 years, Construction in Progress stood at $2.0 billion in 2009, then slumped by 49.19% to $999.0 million in 2010, then increased by 29.53% to $1.3 billion in 2011, then retreated by 26.04% to $957.0 million in 2012, then increased by 15.15% to $1.1 billion in 2013.
• The last three Construction in Progress figures came in at $1.1 billion (Q4 2013), $957.0 million (Q4 2012), and $1.3 billion (Q4 2011), per Business Quant data.